Annual Accounts Payable
$9.75 M
+$1.17 M+13.65%
December 31, 2022
Summary
- As of February 10, 2025, KDNY annual accounts payable is $9.75 million, with the most recent change of +$1.17 million (+13.65%) on December 31, 2022.
- During the last 3 years, KDNY annual accounts payable has risen by +$8.81 million (+938.45%).
Performance
KDNY Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$16.36 M
+$6.59 M+67.40%
June 30, 2023
Summary
- As of February 10, 2025, KDNY quarterly accounts payable is $16.36 million, with the most recent change of +$6.59 million (+67.40%) on June 30, 2023.
- Over the past year, KDNY quarterly accounts payable has increased by +$11.46 million (+233.44%).
Performance
KDNY Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
KDNY Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.7% | +233.4% |
| 3 y3 years | +938.5% | - |
| 5 y5 years | +938.5% | - |
KDNY Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -12.0% | at high | -70.0% |
| 5 y | 5-year | at high | -90.4% | at high | -98.0% |
| alltime | all time | at high | -90.4% | at high | -98.0% |
Chinook Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $16.36 M(+67.4%) |
| Mar 2023 | - | $9.77 M(+0.2%) |
| Dec 2022 | $9.75 M(+13.6%) | $9.75 M(-17.7%) |
| Sep 2022 | - | $11.84 M(+141.3%) |
| Jun 2022 | - | $4.91 M(-45.7%) |
| Mar 2022 | - | $9.04 M(+5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $8.58 M(+114.8%) | $8.58 M(+55.7%) |
| Sep 2021 | - | $5.51 M(-40.2%) |
| Jun 2021 | - | $9.22 M(+25.2%) |
| Mar 2021 | - | $7.36 M(+84.3%) |
| Dec 2020 | $4.00 M(+325.5%) | $4.00 M(+1129.2%) |
| Sep 2020 | - | $325.00 K(-65.4%) |
| Dec 2019 | $939.00 K | $939.00 K |
FAQ
- What is Chinook Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Chinook Therapeutics?
- What is Chinook Therapeutics annual accounts payable year-on-year change?
- What is Chinook Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Chinook Therapeutics?
- What is Chinook Therapeutics quarterly accounts payable year-on-year change?
What is Chinook Therapeutics annual accounts payable?
The current annual accounts payable of KDNY is $9.75 M
What is the all time high annual accounts payable for Chinook Therapeutics?
Chinook Therapeutics all-time high annual accounts payable is $9.75 M
What is Chinook Therapeutics annual accounts payable year-on-year change?
Over the past year, KDNY annual accounts payable has changed by +$1.17 M (+13.65%)
What is Chinook Therapeutics quarterly accounts payable?
The current quarterly accounts payable of KDNY is $16.36 M
What is the all time high quarterly accounts payable for Chinook Therapeutics?
Chinook Therapeutics all-time high quarterly accounts payable is $16.36 M
What is Chinook Therapeutics quarterly accounts payable year-on-year change?
Over the past year, KDNY quarterly accounts payable has changed by +$11.46 M (+233.44%)